Izun Pharmaceuticals Corporation

Day Three Labs Manufacturing Inc.

William Zev Levine

Aron Jay Saffer

Zvi Gerald Loewy

Shmuel Cohen

Shimon Lecht

Gabriel Nussbaum

Aron J Saffer

Mina Fran

Olga Gabay

Aron Saffer

Ilan Feferberg

Amy Debra Rosenbluh

Aron Satter

Mina Faran

Adi Lahiani Hafzadi

Nechama Koren

Zvi G Loewy

Described herein are novel compositions comprising acomponent selected from the group consisting of: a cannabinoid, a flavonoid and a terpenoid; and a protein, selected from the group consisting of whey and a plant protein. According to an embodiment, thecomponent is non-covalently bound to the whey or to the plant protein. The plant protein may be selected from the group consisting of: soy protein, pea protein, rice protein, hemp protein, and hops protein or other plant derived protein.

Protein based cannabis compositions

Described herein are hydrogel compositions comprising extracts ofand. The compositions were found to have improved wound-healing effects. Also described herein are methods for treatment of a wound comprising administering, topically to a patient in need thereof, a therapeutically effective amount of a hydrogel composition comprising extracts ofand

Hydrogel wound treatment

Embodiments of the invention relate to methods for the manufacture of a protein-bound cannabinoid, comprising: obtaining a cannabinoid or cannabis in a form selected from the group consisting of cannabis smoke, cannabis vapor, cannabinoid solution and cannabis extract, and combining the cannabis smoke, vapor, cannabinoid solution or cannabis extract with an aqueous solution or suspension comprising a plasma protein to form a protein-bound cannabinoid. Further embodiments relate to aqueous solutions comprising a plasma protein-bound cannabinoid and pharmaceutical compositions comprising cannabinoids bound to plasma protein.

Water-based cannabinoid and opioid compositions

A method for producing a fatty acid-cannabinoid-plasma protein (FCP) composition, the method comprising: contacting a plasma protein or a peptide portion thereof with a supplemental fatty acid composition comprising at least one fatty acid; and contacting the plasma protein or portion thereof with a cannabinoid composition comprising at least one cannabinoid, such that a combined composition is prepared, which comprises a FCP complex in which the at least one fatty acid and the at least one cannabinoid is bound to the plasma protein or portion thereof.

Stabilized protein-bound cannabinoid compositions

A vapor/smoke capturing trap system featuring a smoke chamber trap for precipitating the smoke dispersed in the chamber. The chamber includes a bottom pool for containing a reservoir of a liquid solvent, and a gas filled portion in which a lower smog portion contains fog-sized droplets of the liquid solvent and into which the smoke is introduced, and an upper clear portion in which the concentration of the smoke and the droplets is decreased, respective of their concentration in the smog portion. A fog-condenser, disposed between the smog portion and the clear portion, precipitates the fog droplets of the smog portion into the pool. A fine mist generator streams a jet of fog-sized droplets of the liquid solvent mixed with smoke toward a concentration of the smoke at the smog portion. A closed loop gas circulator withdraws gas from the clear portion and recirculates the gas under pressure through the fine mist generator into the smog portion. Fresh smoke is introduced into the gas circulator via a smoke conveying conduit. A complementary smoke capturing method includes filling the reservoir, streaming the jet of fog-sized droplets toward a concentration of smoke dispersed within the lower smog portion of the gas filled portion, precipitating droplets, in the smog portion, into the pool by a fog-condenser disposed between the lower smog portion and the upper clear portion of the gas filled portion, recirculating under pressure, in a closed loop gas circulator, gas withdrawn from the clear portion into the smog portion through the fine mist generator, and conducting fresh smoke via smoke conveying conduit into the gas circulator.

Smoke capturing system and method

Embodiments relate to a method for treatment of a sleep disorder and to compositions comprising tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN), wherein the ratio of THC:CBD:CBN by weight is A:B:C where A is between 0.0001 and 1, B is 1, and C is between 0.05 and 1. Optionally A is between 0.001 and 0.02, B is 1 and C is between 0.2 and 0.7.

Cannabinoid compositions and methods of use thereof

Embodiments of the invention relate to a method for the treatment of mIAS or prevention of symptoms associated with mIAS in a patient in need thereof comprising administering to a patient in need thereof an amount of a composition comprising extracts of the plant species, and. Optionally the ratio ofandis about 7:1:2. Further embodiments relate to use of extracts of the plant species, andfor the manufacture of a medicament for the treatment of mIAS or prevention of symptoms associated with mIAS in a patient in need thereof.

Methods for treatment of m-TOR inhibitor-associated stomatitis

The present invention provides therapeutic compositions comprising extracts of the plant speciesandand the extract(s) of at least one further plant selected from the group consisting ofand. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.

Herbal compositions for the treatment of mucosal lesions

Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more ofor, and an effective amount of a quaternary ammonium surfactant.

Topical anti-inflammatory combination

Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more ofor; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s).

Mucosal formulation

Provided, among other things, is a slowly dissolvable film comprising: herbal bioactive agent(s); and polymer(s), dissolvable in the aggregate, wherein the film becomes adhesive as it is placed against a mucosal surface and begins to absorb moisture therefrom.

Growing community of inventors

Jerusalem, Israel

William Zev Levine